Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Castells

Showing results (181-190 of 353) with videos related to

Pageof 36
Sort By:
Cancers|August 27, 2020
Genetic Counseling for Hereditary Gastric and Pancreatic Cancer in High-Risk Gastrointestinal Cancer Clinics: An Effective StrategyJoan Llach, Lorena Moreno, Ariadna Sánchez, et al.
Familial Cancer|March 17, 2015
Pitfalls in the diagnosis of biallelic PMS2 mutationsMarina Antelo, Daniela Milito, Jennifer Rhees, et al.
Clinical and Translational Gastroenterology|May 3, 2021
Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?Ivan Archilla, Sherley Díaz-Mercedes, José Javier Aguirre, et al.
JCI Insight|October 23, 2023
The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomasEster Sánchez-Tilló, Leire Pedrosa, Ingrid Vila, et al.
Plos One|September 17, 2010
Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohortCeres Fernández-Rozadilla, Luisa de Castro, Juan Clofent, et al.
The Journal of Molecular Diagnostics : JMD|May 22, 2010
Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndromeLucía Pérez-Carbonell, Cristina Alenda, Artemio Payá, et al.
Clinical and Translational Gastroenterology|May 29, 2019
Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer RiskIsabel Quintanilla, María López-Cerón, Mireya Jimeno, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2014
RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapyVirginia Alonso-Espinaco, Miriam Cuatrecasas, Vicente Alonso, et al.
Gastroenterologia Y Hepatologia|March 27, 2012
[Timing of polyethylene glycol administration is a key factor in the tolerability and efficacy of colon preparation in colorectal cancer screening]Cristina Rodríguez De Miguel, Anna Serradesanferm, Sabrina Del Manzano, et al.
Applied Health Economics and Health Policy|May 23, 2019
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal CarcinomaSherley Diaz-Mercedes, Ivan Archilla, Jordi Camps, et al.
Pageof 36

Showing results (181-190 of 353) with videos related to

Sort By:
Pageof 36
Cancers|August 27, 2020
Genetic Counseling for Hereditary Gastric and Pancreatic Cancer in High-Risk Gastrointestinal Cancer Clinics: An Effective StrategyJoan Llach, Lorena Moreno, Ariadna Sánchez, et al.
Familial Cancer|March 17, 2015
Pitfalls in the diagnosis of biallelic PMS2 mutationsMarina Antelo, Daniela Milito, Jennifer Rhees, et al.
Clinical and Translational Gastroenterology|May 3, 2021
Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?Ivan Archilla, Sherley Díaz-Mercedes, José Javier Aguirre, et al.
JCI Insight|October 23, 2023
The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomasEster Sánchez-Tilló, Leire Pedrosa, Ingrid Vila, et al.
Plos One|September 17, 2010
Single nucleotide polymorphisms in the Wnt and BMP pathways and colorectal cancer risk in a Spanish cohortCeres Fernández-Rozadilla, Luisa de Castro, Juan Clofent, et al.
The Journal of Molecular Diagnostics : JMD|May 22, 2010
Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndromeLucía Pérez-Carbonell, Cristina Alenda, Artemio Payá, et al.
Clinical and Translational Gastroenterology|May 29, 2019
Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer RiskIsabel Quintanilla, María López-Cerón, Mireya Jimeno, et al.
European Journal of Cancer (Oxford, England : 1990)|May 17, 2014
RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapyVirginia Alonso-Espinaco, Miriam Cuatrecasas, Vicente Alonso, et al.
Gastroenterologia Y Hepatologia|March 27, 2012
[Timing of polyethylene glycol administration is a key factor in the tolerability and efficacy of colon preparation in colorectal cancer screening]Cristina Rodríguez De Miguel, Anna Serradesanferm, Sabrina Del Manzano, et al.
Applied Health Economics and Health Policy|May 23, 2019
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal CarcinomaSherley Diaz-Mercedes, Ivan Archilla, Jordi Camps, et al.
Pageof 36